Intermediate Risk

1

Review clinical trials related to Intermediate Risk. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up

This trial is comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine administration versus decision of radioiodine treatment guided by a post-operative work-up based on serum Tg values and diagnostic RAI scintigraphy

Participants needed: 368
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Centre Francois BaclesseUpdated: Jun 25, 2026Locations: 29
Eligibility criteria

Papillary thyroid cancer (PTC) without aggressive subtype, follicular thyroid ca... [+13]

medullary or anaplastic thyroid cancer [+21]